Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9428
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCooper, Mark Een
dc.contributor.authorMundel, Peteren
dc.contributor.authorBoner, Geoffreyen
dc.date.accessioned2015-05-15T22:31:16Z
dc.date.available2015-05-15T22:31:16Z
dc.date.issued2002-09-01en
dc.identifier.citationSeminars in Nephrology; 22(5): 393-8en
dc.identifier.govdoc12224046en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/9428en
dc.description.abstractNephrin, a newly described protein, has been localized to the slit membrane between adjacent podocytes of the glomerulus. Its discovery followed the demonstration of the gene NPHS1 and its mutation, resulting in the absence of the protein product, nephrin, in the congenital nephrotic syndrome of the Finnish type. The link between permutations in nephrin expression and proteinuria has been shown in animal models by using neutralizing antibodies or studying mice with inactivation of the nephrin gene. Moreover, the expression of nephrin has been shown to be reduced in various animal models of proteinuric renal disease. The relationship between changes in nephrin expression and proteinuric renal disease in humans is not fully elucidated, with a reduction in expression of this protein reported in a range of renal diseases. Diabetic nephropathy, one of the major causes of end-stage renal disease, is associated with substantial proteinuria and in experimental models with a reduction in slit pore density. In experimental models of diabetes, nephrin expression has been described as being transiently increased in the first 8 weeks of diabetes, followed in longer-term studies with reduced nephrin expression in association with increasing proteinuria. An angiotensin II-receptor blocker has been shown to prevent depletion in glomerular nephrin expression in the diabetic kidney. Human studies in both type 1 and type 2 diabetes suggest down-regulation of nephrin expression in the diabetic kidney and it has been postulated that these changes may play a role in the pathogenesis of diabetic nephropathy, specifically the development of proteinuria in this condition. Although there are other proteins involved in the structure of the epithelial podocyte and specifically the slit pore, nephrin seems to play a pivotal role in preventing passage of protein through the glomerular barrier. Furthermore, it is suggested that the antiproteinuric effects of inhibition of the renin-angiotensin system may partly relate to the effects of these agents on nephrin expression.en
dc.language.isoenen
dc.subject.otherAnimalsen
dc.subject.otherDiabetic Nephropathies.complications.physiopathologyen
dc.subject.otherHumansen
dc.subject.otherKidney Diseases.complications.physiopathologyen
dc.subject.otherMembrane Proteinsen
dc.subject.otherProteins.physiologyen
dc.subject.otherProteinuria.complications.physiopathologyen
dc.titleRole of nephrin in renal disease including diabetic nephropathy.en
dc.typeJournal Articleen
dc.identifier.journaltitleSeminars in nephrologyen
dc.identifier.affiliationJDRF Centre for Diabetic Complications, Department of Medicine, University of Melbourne, Austin and Repatriation Medical Centre (Repatriation Campus), Banksia St, West Heidelberg, Australiaen
dc.identifier.affiliationmark.cooper@baker.edu.auen
dc.description.pages393-8en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/12224046en
dc.type.austinJournal Articleen
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Feb 6, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.